Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients.
Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients.
复制标题
犬乳腺肿瘤患者血清和组织中CA15-3、CEA、SF联合检测
DOI:
10.1038/s41598-021-85029-4
复制
发表时间:
2021-03-23
影响因子:
4.6
通讯作者:
Liu Y
中科院分区:
文献类型:
--
作者:
Fan Y;Ren X;Liu X;Shi D;Xu E;Wang S;Liu Y
The purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were determined by ELISA and qRT-PCR assay. CA15-3, CEA, and SF levels of the malignant tumor group were significantly higher than that of the benign tumor group and the healthy control group. In the malignant tumor group, CA15-3 held a sensitivity of 51.8%, a specificity of 93.9%, and an accuracy of 76.8%. The sensitivity, specificity, and accuracy of CEA were 44.6%, 84.1%, and 68.1% respectively. SF held a sensitivity of 62.5%, a specificity of 85.4%, and an accuracy of 76.1%. SF showed the highest sensitivity and CA15-3 showed the highest specificity. The sensitivity, specificity, and accuracy of the combined detection of the three biomarkers in malignant tumor groups were 80.4%, 78.0%, and 80.0%, respectively, therefore combined detection increased sensitivity and accuracy but decreased specificity. In conclusion, the combined detection of serum/tissue markers CA15-3, CEA, and SF may improve the detection sensitivity of CMGTs, providing reference value for clinical application.
登录
查看更多内容
影响因子:
2.7
作者:
Lian, Mingjian;Zhang, Cuixia;Hong, Guolin
通讯作者:
Hong, Guolin
影响因子:
2.4
作者:
Goldschmidt, M.;Pena, L.;Zappulli, V.
通讯作者:
Zappulli, V.
影响因子:
0.5
作者:
Gonssaud, Barbara;Goussot, Vincent;Riedinger, Jean-Marc
通讯作者:
Riedinger, Jean-Marc
影响因子:
5
作者:
Stieber, Petra;Nagel, Dorothea;Di Gioia, Dorit
通讯作者:
Di Gioia, Dorit
影响因子:
2.1
作者:
Kaszak I;Ruszczak A;Kanafa S;Kacprzak K;Król M;Jurka P
通讯作者:
Jurka P